| 发明名称 |
COMBINATION OF HDAC INHIBITORS WITH THROMBOCYTOPENIA DRUGS |
| 摘要 |
The invention relates to a combination which comprises:
(a) a HDAC inhibitor; and(b) an anti-thrombocytopenia drug,
for simultaneous, concurrent, separate or sequential use, especially for use in the treatment of a proliferative diseases. The invention also relates to pharmaceutical compositions or products comprising such a combination, or a method using such a combination |
| 申请公布号 |
US2016199350(A1) |
申请公布日期 |
2016.07.14 |
| 申请号 |
US201514954115 |
申请日期 |
2015.11.30 |
| 申请人 |
Atadja Peter Wisdom;Johnstone Ricky Wayne;Prince Henry Miles;Bishton Mark John;Harrison Simon James |
发明人 |
Atadja Peter Wisdom;Johnstone Ricky Wayne;Prince Henry Miles;Bishton Mark John;Harrison Simon James |
| 分类号 |
A61K31/4045;A61K38/22;A61K31/573;A61K31/4152;A61K38/05 |
主分类号 |
A61K31/4045 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. The combination of (a) N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)-ethyl]-amino]methyl]phenyI]-2E-2-propenamide, or a pharmaceutically acceptable salt thereof in combination with (b) an anti-thrombocytopenia drug. |
| 地址 |
Acton MA US |
